Literature DB >> 34716416

The Port Delivery System with ranibizumab-journey of mitigating vitreous hemorrhage.

Ashish Sharma1, Nikulaa Parachuri2,3, Nilesh Kumar2,4, Baruch D Kuppermann5, Francesco Bandello6.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2021        PMID： 34716416      PMCID： PMC8873447          DOI： 10.1038/s41433-021-01830-5

Source DB:  PubMed          Journal:  Eye (Lond)        ISSN： 0950-222X            Impact factor:   3.775


× No keyword cloud information.
  1 in total

1.  EVALUATION OF SURGICAL FACTORS AFFECTING VITREOUS HEMORRHAGE FOLLOWING PORT DELIVERY SYSTEM WITH RANIBIZUMAB IMPLANT INSERTION IN A MINIPIG MODEL.

Authors:  Vladimir Bantseev; Chris Schuetz; Helen S Booler; Joshua Horvath; Kristof Hovaten; Signe Erickson; Ellison Bentley; T Michael Nork; William R Freeman; Jay M Stewart; Giulio Barteselli
Journal:  Retina       Date:  2020-08       Impact factor: 3.975
  1 in total
  2 in total

1.  Hyaluronic Acid-PEG-Based Diels-Alder In Situ Forming Hydrogels for Sustained Intraocular Delivery of Bevacizumab.

Authors:  Blessing C Ilochonwu; Marko Mihajlovic; Roel F Maas-Bakker; Charis Rousou; Miao Tang; Mei Chen; Wim E Hennink; Tina Vermonden
Journal:  Biomacromolecules       Date:  2022-06-23       Impact factor: 6.978

Review 2.  Polymeric biomaterials in the treatment of posterior segment diseases.

Authors:  Ivan Seah; Charles Ong; Zengping Liu; Xinyi Su
Journal:  Front Med (Lausanne)       Date:  2022-08-18
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.